Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stock market
Pharma
Hansa eyes US listing ahead of FDA verdict on Idefirix
With the FDA expected to decide on its kidney transplant drug before year-end, Hansa Biopharma is mulling its stock listing options in the U.S.
Fraiser Kansteiner
Aug 24, 2026 2:45pm
AstraZeneca plots NYSE listing amid UK industry pullback
Sep 29, 2025 10:05am
UPDATED: AstraZeneca stock tanks over fears of more China probe
Nov 5, 2024 3:13pm
ImmunityBio gets FDA snub on cancer drug, shares crash
May 11, 2023 9:40am
Valneva shares slide in wake of EU COVID contract vax slash
Jul 21, 2022 9:35am
